Jazz Pharmaceuticals: all 223 studies

Page 1 of 3. Open to participants first (19), then studies with results posted, then the rest; newest registration first within each.

• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JZP269 in Healthy Male and Female ParticipantsNot yet recruitingNCT07813663Phase 1
• Zanidatamab Outcomes and Lived Experiences in Advanced HER2+ GEANot yet recruitingNCT07780968
• A Study to Investigate the Effect of Gradual Titration to Optimize Cannabidiol Treatment in Adults With LGSNot yet recruitingNCT07728097Phase 4
• A Study to Evaluate the Safety and Efficacy of CBD-OS in Participants With DEENot yet recruitingNCT07723976Phase 3
• A Study to Evaluate the Safety and Efficacy of JZP926 Capsule for the Treatment of Juvenile Myoclonic EpilepsyRecruitingNCT07723963Phase 2/3
• A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IHRecruitingNCT07625280Phase 3
• A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 MeningiomaRecruitingNCT07533942Phase 2
• A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLCRecruitingNCT07459634Phase 2
• Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and ParagangliomaRecruitingNCT07282587Phase 2
• A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset SeizuresRecruitingNCT07233239Phase 1
• A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast CancerRecruitingNCT07102381Phase 2
• A Phase 2 Study of Zanidatamab in Patients With HER2-expressing TumorsRecruitingNCT06695845Phase 2
• A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast CancerRecruitingNCT06435429Phase 3
• Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract CancerRecruitingNCT06282575Phase 3
• Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During PregnancyRecruitingNCT06113237
• JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid TumorsRecruitingNCT06108050Phase 1
• Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing SarcomaRecruitingNCT05734066Phase 1/2
• ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)RecruitingNCT05580562Phase 3
• Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System NeoplasmsRecruitingNCT04541082Phase 1
• A Study to Investigate the Effect of XYWAV on Sleepiness, Polysomnography, and Functional Outcomes in Participants With Idiopathic Hypersomnia or NarcolepsyCompletedNCT05875974Phase 4Results posted
• A Switch Study From High-Sodium Oxybate to Xywav to Evaluate Changes in Blood Pressure in Participants With NarcolepsyCompletedNCT05869773Phase 4Results posted
• A Study of Suvecaltamide in Adults With Moderate to Severe Residual Tremor in Parkinson's DiseaseCompletedNCT05642442Phase 2Results posted
• Efficacy and Safety of GWP42003-P Oral Solution in Children With Epilepsy With Myoclonic-atonic SeizuresTerminatedNCT05288283Phase 3Results posted
• A Study of JZP150 in Adults With Posttraumatic Stress DisorderCompletedNCT05178316Phase 2Results posted
• Lurbinectedin Monotherapy in Participants With Advanced or Metastatic Solid TumorsTerminatedNCT05126433Phase 2Results posted
• A Study To Assess the Safety and Efficacy of JZP385 in the Treatment of Adults With Moderate to Severe Essential Tremor (ET)CompletedNCT05122650Phase 2Results posted
• Evaluation of the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple SclerosisTerminatedNCT04984278Phase 3Results posted
• An Interventional Safety Switch Study (Segue Study) of XYWAV in NarcolepsyCompletedNCT04794491Phase 4Results posted
• Trial to Investigate the Safety and Efficacy of Cannabidiol Oral Solution (GWP42003-P; CBD-OS) in Children and Adolescents With Autism Spectrum DisorderCompletedNCT04745026Phase 2Results posted
• Trial to Evaluate the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple SclerosisCompletedNCT04657666Phase 3Results posted
• Dociparstat in Combination With Standard Chemotherapy for the Treatment of Acute Myeloid LeukemiaTerminatedNCT04571645Phase 3Results posted
• Assessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) in Children With Tuberous Sclerosis Complex (TSC), Dravet Syndrome (DS), or Lennox-Gastaut Syndrome (LGS) Who Experience Inadequately-controlled SeizuresTerminatedNCT04485104Phase 3Results posted
• A Study of ZW25 (Zanidatamab) in Subjects With Advanced or Metastatic HER2-Amplified Biliary Tract CancersCompletedNCT04466891Phase 2Results posted
• Trial to Investigate the Safety and Efficacy of GWP42003-P Versus Placebo as Adjunctive Therapy in Participants With Schizophrenia Experiencing Inadequate Response to Ongoing Antipsychotic TreatmentTerminatedNCT04421456Phase 2Results posted
• Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory FailureTerminatedNCT04389840Phase 2/3Results posted
• A Long-term Safety Study of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett SyndromeTerminatedNCT04252586Phase 3Results posted
• Phase 2a Study of ZW25 in Combination With Palbociclib Plus FulvestrantCompletedNCT04224272Phase 2Results posted
• Safety and Effectiveness of Nabiximols Oromucosal Spray as Add-on Therapy in Participants With Spasticity Due to Multiple SclerosisTerminatedNCT04203498Phase 3Results posted
• An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)CompletedNCT04145531Phase 2/3Results posted
• A Safety and Efficacy Study of Defibrotide in the Prevention of Chimeric Antigen Receptor-T-cell-associated NeurotoxicityTerminatedNCT03954106Phase 2Results posted
• Efficacy and Safety of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett SyndromeTerminatedNCT03848832Phase 3Results posted
• A Multicenter Study of the Efficacy and Safety of JZP-258 in the Treatment of Idiopathic Hypersomnia (IH) With an Open-label Safety ExtensionCompletedNCT03533114Phase 3Results posted
• ONC201 in Recurrent or Metastatic Type II Endometrial Cancer Endometrial CancerTerminatedNCT03485729Phase 2Results posted
• CX-8998 for Absence SeizuresCompletedNCT03406702Phase 2Results posted
• The AdAPT Trial; Adenovirus After Allogeneic Pediatric TransplantationTerminatedNCT03339401Phase 2Results posted
• An Open-Label Study of Defibrotide for the Prevention of Acute Graft-versus-Host-Disease (AGvHD)CompletedNCT03339297Phase 2Results posted
• ONC201 in Adults With Recurrent H3 K27M-mutant GliomaTerminatedNCT03295396Phase 2Results posted
• A Phase 2 RCT Study of CX-8998 for Essential TremorCompletedNCT03101241Phase 2Results posted
• A 4-Week Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive SleepinessCompletedNCT03037203Phase 2Results posted
• A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With CataplexyCompletedNCT03030599Phase 3Results posted
• Phase 3 Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms: Open-label Extension Phase (GWPCARE7)CompletedNCT02954887Phase 3Results posted
• Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms (GWPCARE7)CompletedNCT02953548Phase 3Results posted
• Dociparstat Sodium (CX-01) Combined With Standard Induction Therapy for Newly Diagnosed Acute Myeloid LeukemiaCompletedNCT02873338Phase 2Results posted
• Oral ONC201 in Relapsed/Refractory Multiple MyelomaTerminatedNCT02863991Phase 1/2Results posted
• Study Comparing Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric PatientsCompletedNCT02851407Phase 3Results posted
• Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in NarcolepsyCompletedNCT02806908Phase 2Results posted
• Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in OSACompletedNCT02806895Phase 2Results posted
• A Randomized Controlled Trial to Investigate Possible Drug-drug Interactions Between Clobazam and CannabidiolCompletedNCT02565108Phase 2Results posted
• An Open-label Extension Study to Investigate Possible Drug-drug Interactions Between Clobazam and CannabidiolCompletedNCT02564952Phase 2Results posted
• A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)CompletedNCT02544763Phase 3Results posted
• An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)CompletedNCT02544750Phase 3Results posted
• Oral ONC201 in Adult Recurrent GlioblastomaTerminatedNCT02525692Phase 2Results posted
• A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus DiseaseTerminatedNCT02439970Phase 3Results posted
• A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of CytomegalovirusTerminatedNCT02439957Phase 3Results posted
• "A Long-Term Safety Study of JZP-110 in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or OSA"CompletedNCT02348632Phase 3Results posted
• "Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"CompletedNCT02348619Phase 3Results posted
• "Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"CompletedNCT02348606Phase 3Results posted
• "Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in Narcolepsy"CompletedNCT02348593Phase 3Results posted
• A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)TerminatedNCT02257684Phase 2Results posted
• An Open Label Phase II Pharmacokinetic and Pharmacodynamic Assessment of the Potential for QTc Prolongation Following First Induction Treatment With CPX-351 (Cytarabine:Daunorubicin) Liposome Injection in Acute Leukemias and MDS PatientsCompletedNCT02238925Phase 2Results posted
• GWPCARE2 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet SyndromeCompletedNCT02224703Phase 3Results posted
• A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and AdultsCompletedNCT02224690Phase 3Results posted
• An Open Label Extension Study of Cannabidiol (GWP42003-P) in Children and Adults With Dravet or Lennox-Gastaut SyndromesCompletedNCT02224573Phase 3Results posted
• Efficacy and Safety of GWP42003-P for Seizures Associated With Lennox-Gastaut Syndrome in Children and AdultsCompletedNCT02224560Phase 3Results posted
• A Multicenter Study of the Efficacy and Safety of Xyrem With an Open- Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects With Narcolepsy With CataplexyCompletedNCT02221869Phase 3Results posted
• Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1)CompletedNCT02091375Phase 3Results posted
• A Dose-ranging Pharmacokinetics and Safety Study of GWP42003-P in Children With Dravet Syndrome (GWPCARE1)CompletedNCT02091206Phase 2Results posted
• Study to Assess the Safety and Efficacy of Brincidofovir in Treatment of Early Versus Late Adenovirus InfectionCompletedNCT02087306Phase 3Results posted
• A Pilot Study of Dociparstat Sodium (ODSH) in Acute Myeloid LeukemiaCompletedNCT02056782Phase 1Results posted
• A Study of GWP42003 as Adjunctive Therapy in the First Line Treatment of Schizophrenia or Related Psychotic DisorderCompletedNCT02006628Phase 2Results posted
• A Randomized Study of Sativex on Cognitive Function and Mood: Multiple Sclerosis PatientsCompletedNCT01964547Phase 4Results posted
• A Study of the Safety and Efficacy of CMX001 for the Prevention of CMV Infection in CMV-seropositive HCT RecipientsCompletedNCT01769170Phase 3Results posted
• Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid LeukemiaCompletedNCT01696084Phase 3Results posted
• A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With NarcolepsyCompletedNCT01681121Phase 2Results posted
• A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase TherapyCompletedNCT01643408Phase 2Results posted
• An Study to Investigate the Efficacy of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple SclerosisCompletedNCT01610713Phase 3Results posted
• An Investigation of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis PatientsCompletedNCT01610700Phase 3Results posted
• A Long-term Safety Extension Study of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple SclerosisCompletedNCT01610687Phase 3Results posted
• A Study of Cannabis Based Medicine Extracts and Placebo in Patients With Pain Due to Spinal Cord InjuryCompletedNCT01606202Phase 3Results posted
• A Study to Compare Sublingual Cannabis Based Medicine Extracts With Placebo to Treat Brachial Plexus Injury PainCompletedNCT01606189Phase 3Results posted
• A Study to Evaluate the Effects of Cannabis Based Medicine in Patients With Pain of Neurological OriginCompletedNCT01606176Phase 3Results posted
• A Study of the Long-term Safety of Sativex UseCompletedNCT01606137Phase 3Results posted
• A Study of Sativex in the Treatment of Central Neuropathic Pain Due to Multiple SclerosisCompletedNCT01604265Phase 3Results posted
• A Study to Evaluate the Efficacy of Sativex in Relieving Symptoms of Spasticity Due to Multiple SclerosisCompletedNCT01599234Phase 3Results posted
• A Pilot Study of GWP42003 in the Symptomatic Treatment of Ulcerative Colitis (GWID10160)CompletedNCT01562314Phase 2Results posted
• Treatment on Iatrogenic Weight Gain and Dyslipidaemia Associated With OlanzapineTerminatedNCT01491490Phase 2Results posted
• A Study of the Safety and Effectiveness of ADX-N05 in the Treatment of Excessive Daytime SleepinessCompletedNCT01485770Phase 2Results posted
• A Two-Part Study of Sativex® Oromucosal Spray for Relieving Uncontrolled Persistent Pain in Patients With Advanced CancerCompletedNCT01424566Phase 3Results posted
• Sativex® for Relieving Persistent Pain in Patients With Advanced CancerCompletedNCT01361607Phase 3Results posted
• Long Term Safety of Sativex Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related PainCompletedNCT01337089Phase 3Results posted

← Jazz Pharmaceuticals overview and focus areas